Tobacco Cessation Clinical Trial
Official title:
Tobacco Cessation Treatment for Alaska Native Youth
Verified date | May 2013 |
Source | Mayo Clinic |
Contact | n/a |
Is FDA regulated | No |
Health authority | United States: Federal Government |
Study type | Interventional |
Tobacco use among adolescents is a major public health problem in the United States. The
prevalence of tobacco use among adolescents is currently highest among American Indians and
Alaska Natives. Among Alaska Natives residing in the Yukon-Kuskokwim (Y-K) Delta region of
western Alaska, approximately 29% of 11-14 year olds, and 63% of 15-18 year olds, use
tobacco. No prior work has evaluated tobacco cessation interventions for Alaska Native
adolescents.
This proposal builds on the investigators successful partnership and 7 year track record of
collaboration with the Y-K Delta Alaska Native community. The objective of this proposal is
to develop and pilot test a novel, culturally-appropriate, behavioral treatment approach for
tobacco cessation among Y-K Delta Alaska Native adolescents ages 12 to 17. The behavioral
intervention will include an initial, 2 day, group-based program with follow-up support for
6 weeks. Social cognitive (learning) theory is the conceptual basis for the proposed
intervention. The investigators expect that as a result of this stage I project, the
investigators will have developed a replicable, feasible, and acceptable intervention, the
efficacy of which can be tested in future large-scale randomized clinical trials.
This project will take place in two phases. In phase 1, the investigators will develop the
intervention with feedback from a teen advisory group, and develop a counselor manual.
Follow-up strategies will also be developed, pilot-tested, and refined. Twenty adolescents
will complete the protocol, which will be refined in an iterative manner based on feedback
from participants and counselors. Phase 2, consisting of a pilot clinical trial, will apply
a group-randomized design with assessments at weeks 0 (baseline), 6, and 26. Eight villages
will be randomized to receive either the behavioral intervention or control condition
(written self-help materials + quitline referral). Ten adolescents will be enrolled from
each village, for a total of 80 participants. The investigators will assess the feasibility
and acceptability of the intervention, as determined by qualitative ratings of treatment
acceptability, and recruitment and retention rates. The investigators will estimate the
magnitude of the effect of the intervention compared to the control condition on the
biochemically confirmed tobacco abstinence rate at weeks 6 and 26, and estimate the
intra-class correlation coefficient (ICC). At week 6, the investigators will evaluate the
effect of the intervention on changes from baseline on perceived social support,
self-efficacy for stopping tobacco use, and other mechanisms of change consistent with the
investigators theoretical framework. The overall health related objective is to develop
effective treatment programs for Alaska Native youth that will ultimately reduce their risk
of tobacco-related disease.
Status | Completed |
Enrollment | 100 |
Est. completion date | July 2012 |
Est. primary completion date | July 2012 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Both |
Age group | 12 Years to 17 Years |
Eligibility |
Inclusion Criteria: 1. Alaska Native 2. is from one of the targeted villages 3. is between 12-17 years of age 4. provides written assent 5. provides written parental consent 6. self-reports daily use of Iqmik, commercial ST, and/or cigarette smoking during the past 7 days, with current tobacco use status verified with a NicAlert salivary cotinine test strip value of >0 7. is willing to make a quit attempt 8. is willing and able to participate in all aspects of the study 9. has access to Web/e-mail and a working telephone. Exclusion Criteria: 1. the adolescent is not able to fully participate in the intervention or would potentially pose harm to self or other group participants, and/or disrupt the group process (e.g., if subject is intoxicated at screening) 2. depression score of >16 as assessed by the Center for Epidemiological Studies Depression Scale (CES-D; Radloff, 1977) 3. current (past 3 months) participation in any tobacco pharmacological or behavioral treatment 4. another adolescent from the same household has enrolled. |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
United States | Yukon Kuskokwim Health Corporation | Bethel | Alaska |
Lead Sponsor | Collaborator |
---|---|
Mayo Clinic | Yukon Kuskokwim Health Corporation |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Feasibility of recruitment | Assessed at the time of screening | No | |
Secondary | Biochemically confirmed tobacco abstinence | Assessed at Week 6 (End of Treatment) | No | |
Secondary | Study retention | Assessed at week 24 | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Enrolling by invitation |
NCT05415371 -
Persistent Poverty Counties Pregnant Women With Medicaid
|
N/A | |
Not yet recruiting |
NCT04501016 -
A Stepped Care Approach to Treating Tobacco Use in Rural Veterans
|
Phase 2/Phase 3 | |
Completed |
NCT01570595 -
Positively Smoke Free on the Web (PSFW) for Smokers Living With HIV
|
Phase 1/Phase 2 | |
Completed |
NCT01651611 -
Intervention Study to Increase Smoking Cessation Rates Among Public Housing Residents
|
N/A | |
Completed |
NCT01164306 -
The Impact of a Tobacco Control Intervention in African-American Families
|
N/A | |
Recruiting |
NCT04865276 -
Adaptation and Evaluation of a Culturally and Gender Relevant Tobacco Cessation Among Women in Brazil: An Integrated mHealth Approach
|
N/A | |
Recruiting |
NCT02103868 -
Medium Vs Low Intensity Intervention in Tobacco Cessation and Control in Zari Workers
|
N/A | |
Completed |
NCT00836199 -
NicVAX/Placebo as an Aid for Smoking Cessation
|
Phase 3 | |
Recruiting |
NCT05552534 -
Impact of an Intervention of Screening, Treatment Initiation and Referral to PROmote Smoking CEssation in Emergency Department Patients
|
N/A | |
Completed |
NCT01482923 -
Tobacco Assessment and Intervention With Low-Income Persons Living With HIV-AIDS (PLWHA) in Community-Based AIDS Service Organizations
|
||
Completed |
NCT05764343 -
The Effect of Immediate Smoking Cessation Interventions for Smokers With Chronic Airway Diseases
|
N/A | |
Completed |
NCT01312480 -
Adolescent Smoking Cessation in Pediatric Primary Care
|
N/A | |
Completed |
NCT03377738 -
Effectiveness of the Spirometry Test as a Motivational Tool for Quitting Tobacco in Primary Care
|
N/A | |
Completed |
NCT03096145 -
Support Person Intervention to Promote a Smoking Helpline Among Under Resourced Smokers
|
N/A | |
Completed |
NCT05095779 -
Incentives for Smoking Cessation in Persistent Poverty Counties
|
N/A | |
Completed |
NCT03062709 -
A Study of Tobacco Smoke and Children With Respiratory Illnesses
|
N/A | |
Completed |
NCT00750503 -
Workplace Tobacco Cessation And Oral Cancer Screening Study
|
Phase 3 | |
Withdrawn |
NCT04340102 -
Development of a Scalable Intervention to Improve Smoking Cessation in Persons With Serious Mental Illness
|
N/A | |
Completed |
NCT01331226 -
Support Person Intervention to Promote a Smoking Helpline
|
N/A | |
Completed |
NCT04198688 -
Effectiveness of Intensive Smoking Cessation Interventions in Patients With Cancer
|